John B. Briggs

High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR

Robert L. Shields, Angela K. Namenuk, Kyu Hong et al. · Journal of Biological Chemistry · 2001 · 1.2K citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics

T. Shantha Raju, John B. Briggs, Sarah Borge et al. · Glycobiology · 2000 · 455 citations

Life Sciences, Biochemistry, Molecular Biology +17

Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins

Stefanie Weikert, Damon I. Papac, John B. Briggs et al. · Nature Biotechnology · 1999 · 200 citations

Life Sciences, Biochemistry, Molecular Biology +16

Glycoengineering of Therapeutic Glycoproteins:  In Vitro Galactosylation and Sialylation of Glycoproteins with Terminal <i>N</i>-Acetylglucosamine and Galactose Residues

T. Shantha Raju, John B. Briggs, Steven M. Chamow et al. · Biochemistry · 2001 · 120 citations

Life Sciences, Biochemistry, Immunology +17

An analytical system for the characterization of highly heterogeneous mixtures of N-linked oligosaccharides

John B. Briggs, Rodney G. Keck, Stacey Ma et al. · Analytical Biochemistry · 2009 · 24 citations

Life Sciences, Biochemistry, Chemistry +16